A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA - Sorbonne Université Access content directly
Journal Articles (Data Paper) Journal of Hepatology Year : 2021

A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA

Gideon M Hirschfield
Ulrich Beuers
Limas Kupcinskas
  • Function : Author
Peter Ott
  • Function : Author
Annika Bergquist
  • Function : Author
Martti Färkkilä
  • Function : Author
Michael P Manns
  • Function : Author
Albert Parés
  • Function : Author
Ulrich Spengler
  • Function : Author
Michael Stiess
Roland Greinwald
  • Function : Author
Markus Pröls
  • Function : Author
Uta Drebber
  • Function : Author
Raoul Poupon
  • Function : Author

Abstract

Placebo + 12-16 mg/kg UDCA N = 22 9 mg Budesonide + 12-16 mg/kg UDCA N = 40
Fichier principal
Vignette du fichier
1-s2.0-S0168827820336230-main.pdf (758.2 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03972157 , version 1 (15-03-2023)

Identifiers

Cite

Gideon M Hirschfield, Ulrich Beuers, Limas Kupcinskas, Peter Ott, Annika Bergquist, et al.. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA. Journal of Hepatology, 2021, 74 (2), pp.321-329. ⟨10.1016/j.jhep.2020.09.011⟩. ⟨hal-03972157⟩
11 View
14 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More